Form 4: ATAI Life Sciences CFO Anne Nagengast Johnson Sells Shares to Cover Tax Obligations

Anne Nagengast Johnson, CFO of ATAI Life Sciences N.V., sold 27,410 common shares on April 2, 2024, at a price of $1.85 per share to cover tax liabilities related to vesting restricted stock units.

Summary

• On April 2, 2024, Anne Nagengast Johnson, the Chief Financial Officer of ATAI Life Sciences N.V., sold 27,410 common shares of the company.
• The shares were sold at a price of $1.85 per share.
• The transaction was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Johnson directly owns 73,590 common shares of ATAI Life Sciences N.V.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a stock sale for tax purposes, which is neutral in sentiment.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale of shares by the CFO could have a minor impact on shareholders, potentially causing a slight decrease in share price due to increased selling pressure, but this is likely to be minimal.

Key Dates